Kadima Ngomba, Baldeh Tejan, Thin Kyaw, Thabane Lehana, Mbuagbaw Lawrence
Queen Mamahato Memorial Hospital, Maseru, Lesotho-CTN International Postdoctoral Fellow.
Department of Health Research Methods, Evidence and Impact McMaster University, Hamilton, Canada.
Pan Afr Med J. 2018 Jul 31;30:239. doi: 10.11604/pamj.2018.30.239.14532. eCollection 2018.
Success in addressing prevention of mother-to-child transmission of HIV depends largely on good adherence to anti-retroviral therapy (ART) by pregnant women. Knowledge of the levels of ART adherence among pregnant women is essential to inform strategies to prevent or reduce HIV transmission rates, particularly in African settings. Aim: the primary objective of this study was to measure adherence to anti-retroviral therapy (ART) among pregnant women living with human immunodeficiency virus (HIV). The secondary objectives were to determine: i) the rate of new infections among children at Mabote Filter Clinic in Maseru, Lesotho whose mothers were enrolled in PMTCT, and ii) the factors associated with non-adherence to ART among pregnant women.
In this prospective cohort study, HIV-positive pregnant women receiving antiretroviral therapy (ART) for prevention of mother to child transmission (PMTCT) were followed up to delivery and their children were tested for HIV. We collected socio-demographic information, knowledge of PMTCT and adherence to ART (three-day recall and pill count) including reasons for non-adherence. We also used logistic regression to explore factors associated with non-adherence.
One hundred and seven women were included. The mean (standard deviation) age of the participants was 28.2 (5.7) years. Most, 81.3% (87/107), were married, only 9.3% (10/107) had a postsecondary education. Two-thirds (63.6%: 68/107) of the participants started ART because of PMTCT. Only 78.5% (84/107) of the participants had adequate knowledge of the importance of PMTCT. The three-day self-reported non-adherence rate at the first visit was 7.5% (95% confidence interval (CI): 3.7, 13.1), but up to 43.4% (95% CI: 35.2, 51.9) using pill count. The most frequently reported reasons for not adhering were: running out of pills (7.5%), nausea (5.6%) and to avoid side-effects (3.7%). Women who were employed (odds ratio (OR) 4.35; 95% CI: 1.38,14.29; p = 0.012) and at a higher gestational age (OR = 1.43; 95% CI: 1.11, 1.85; p = 0.006) were more likely to be non-adherent. Only 1 of the 77 exposed infants was found to be positive for HIV at 6 weeks after birth.
We found a higher non-adherence rate for participants with pill count compared to a three-day adherence self-report. However, mother to child HIV transmission was relatively low. Lack of employment and relatively high gestational age were found to be predictive factors of non-adherence.
在预防艾滋病毒母婴传播方面取得成功很大程度上取决于孕妇对抗逆转录病毒疗法(ART)的良好依从性。了解孕妇的抗逆转录病毒疗法依从水平对于制定预防或降低艾滋病毒传播率的策略至关重要,尤其是在非洲地区。目的:本研究的主要目标是测量感染人类免疫缺陷病毒(HIV)的孕妇对抗逆转录病毒疗法(ART)的依从性。次要目标是确定:i)在莱索托马塞卢的马博特过滤诊所,其母亲参加预防母婴传播(PMTCT)项目的儿童中的新感染率,以及ii)与孕妇抗逆转录病毒疗法不依从相关的因素。
在这项前瞻性队列研究中,对接受抗逆转录病毒疗法(ART)以预防母婴传播(PMTCT)的HIV阳性孕妇进行随访直至分娩,并对其子女进行HIV检测。我们收集了社会人口学信息、预防母婴传播知识以及抗逆转录病毒疗法的依从性(三日回忆法和药丸计数),包括不依从的原因。我们还使用逻辑回归来探究与不依从相关的因素。
纳入了107名女性。参与者的平均(标准差)年龄为28.2(5.7)岁。大多数人(81.3%:87/107)已婚,只有9.3%(10/107)拥有大专以上学历。三分之二(63.6%:68/107)的参与者因预防母婴传播而开始接受抗逆转录病毒疗法。只有78.5%(84/107)的参与者充分了解预防母婴传播的重要性。首次就诊时三日自我报告的不依从率为7.5%(95%置信区间(CI):3.7,13.1),但使用药丸计数法时高达43.4%(95%CI:35.2,51.9)。最常报告的不依从原因是:药丸用完(7.5%)、恶心(5.6%)以及避免副作用(3.7%)。就业的女性(优势比(OR)4.35;95%CI:1.38,14.29;p = 0.012)和孕周较大的女性(OR = 1.43;95%CI:1.11,1.85;p = 0.006)更有可能不依从。在77名暴露婴儿中,只有1名在出生后6周被检测出HIV呈阳性。
我们发现与三日依从性自我报告相比,使用药丸计数法的参与者不依从率更高。然而,艾滋病毒母婴传播率相对较低。发现未就业和孕周相对较大是不依从的预测因素。